ArticleImmunoHorizons2025

Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1-5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy.

Sayaka Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.